Hibiscus Sabdariffa and Centella Asiatica in the Treatment of Anemia by Iron Deficiency
Launched by CASA ESPIRITA TERRA DE ISMAEL · Aug 10, 2011
Trial Information
Current as of June 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 y and \< 50 y
- • A diagnostic of iron deficient anemia
- Exclusion Criteria:
- • Severe anemia
- • Treatment interruption for more than 25% of the 6 weeks
- • New onset severe adverse symptoms or events
- • Patient's request
About Casa Espirita Terra De Ismael
Casa Espírita Terra de Ismael is a dedicated clinical trial sponsor committed to advancing medical research and enhancing patient care through innovative studies grounded in ethical practices and community engagement. With a focus on holistic well-being and spiritual health, the organization strives to foster collaboration among researchers, healthcare professionals, and participants, ensuring that trials are conducted with integrity and transparency. By leveraging its unique perspective on health and wellness, Casa Espírita Terra de Ismael aims to contribute to the development of effective treatments and therapies that address the needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Monte Santo De Minas, Minas Gerais, Brazil
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials